Lv5
1270 积分 2022-07-05 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
1天前
待确认
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
6天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
6天前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
6天前
已完结
Emerging principles of cytokine pharmacology and therapeutics
14天前
已完结
Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy
14天前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
1个月前
已完结
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy
1个月前
已完结
RNA interference in the era of nucleic acid therapeutics
2个月前
已完结
Protein degraders push into novel target space
2个月前
已完结
皖公网安备34019202002308
